This website contains promotional content and is intended for Healthcare Professionals based in the United Kingdom only. Some content is only relevant to HCPs practising in Great Britain (England, Scotland, Wales). This website is optimised for desktop use, and some features may perform differently on mobile devices.

Adverse event reporting can be found at the bottom of the page.

Campus
  1. Education
  2. Source: Campus Sanofi
  3. 1 Jun 2024
2 min

EBMT 2024: Frontline treatment of chronic GvHD

Author: Francesca Bonifazi

Editorial Team

Rezurock▼ (Belumosudil) is intended for HCPs practising in Great Britain (England, Scotland and Wales) only.

Frontline treatment of chronic GvHD

Length: 15mins

In this video, Dr Francesca Bonifazi discusses the current treatment paradigm for chronic GvHD. She explores frontline options and appropriate patient populations. Dr Bonifazi highlights the need for early intervention with cGvHD and how this may improve outcomes.

Advances in the biology of chronic GvHD

Treatment of steroid refractory chronic GvHD

QoL and chronic GvHD

Roundtable discussion: Exploring clinical cases

Expanding the cGvHD treatment paradigm with novel therapeutics

Expert exchange: Exploring the clinical practicalities of managing GvHD

The late effects of chronic GvHD: The challenge of long-term management

Pulmonary chronic GvHD: The need for early identification and improved management

1/8

Advances in the biology of chronic GvHD

Treatment of steroid refractory chronic GvHD

QoL and chronic GvHD

Roundtable discussion: Exploring clinical cases

Expanding the cGvHD treatment paradigm with novel therapeutics

Expert exchange: Exploring the clinical practicalities of managing GvHD

The late effects of chronic GvHD: The challenge of long-term management

Pulmonary chronic GvHD: The need for early identification and improved management

1/3
Rezurock logo with man

Get the latest updates about REZUROCK

This is intended for HCPs practising in Great Britain (England, Scotland, Wales) only.

ROCKstar Study

Download ROCKstar study summary. This is intended for HCPs practising in Great Britain (England, Scotland, Wales) only​.

1/2
Rezurock logo with man

Get the latest updates about REZUROCK

This is intended for HCPs practising in Great Britain (England, Scotland, Wales) only.

ROCKstar Study

Download ROCKstar study summary. This is intended for HCPs practising in Great Britain (England, Scotland, Wales) only​.

Get in touch with the Transplant Team
MAT-XU-2201545 (v5.0) Date of Preparation: October 2023

MAT-XU-2402246 (v1.0) Date of Preparation: August 2024